Romiplostim as an early treatment for refractory immune thrombocytopenia in a 2-month-old infant

被引:0
作者
Chiba, Yuko [1 ]
Tasaka, Keiji [1 ,5 ]
Matsubara, Kousaku [2 ]
Mori, Makiko [3 ]
Muraoka, Michiko [4 ]
Hamabata, Takayuki [1 ]
Nodomi, Seishiro [1 ]
Waki, Kenji [1 ]
机构
[1] Kurashiki Cent Hosp, Dept Pediat, Okayama, Japan
[2] Kobe City Nishi Kobe Med Ctr, Dept Pediat, Kobe, Japan
[3] Saitama Childrens Med Ctr, Dept Hematol Oncol, Saitama, Japan
[4] Fukuyama City Hosp, Dept Pediat, Hiroshima, Japan
[5] Kurashiki Cent Hosp, Dept Pediat, 1-1-1 Miwa, Kurashiki 7108602, Japan
关键词
RANDOMIZED-TRIAL; ORAL PREDNISONE; DOUBLE-BLIND; CHILDREN; ELTROMBOPAG; ITP; MULTICENTER; EFFICACY; THERAPY; SAFETY;
D O I
10.1002/pbc.30953
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:3
相关论文
共 20 条
  • [1] First Line Treatments for Newly Diagnosed Primary Immune Thrombocytopenia in Children: A Systematic Review and Network Meta-analysis
    Acero-Garces, David O.
    Garcia-Perdomo, Herney A.
    [J]. CURRENT PEDIATRIC REVIEWS, 2020, 16 (01) : 61 - 70
  • [2] Long-term outcomes after splenectomy in children with immune thrombocytopenia: an update on the registry data from the Intercontinental Cooperative ITP Study Group
    Avila, Maria L.
    Amiri, Nour
    Pullenayegum, Eleanor
    Blanchette, Victor
    Imbach, Paul
    Kuhne, Thomas
    [J]. HAEMATOLOGICA, 2020, 105 (11) : 2682 - 2685
  • [3] RANDOMIZED TRIAL OF INTRAVENOUS IMMUNOGLOBULIN-G, INTRAVENOUS ANTI-D, AND ORAL PREDNISONE IN CHILDHOOD ACUTE IMMUNE THROMBOCYTOPENIC PURPURA
    BLANCHETTE, V
    IMBACH, P
    ANDREW, M
    ADAMS, M
    MCMILLAN, J
    WANG, E
    MILNER, R
    ALI, K
    BARNARD, D
    BERNSTEIN, M
    CHAN, KW
    ESSELTINE, D
    DEVEBER, B
    ISRAELS, S
    KOBRINSKY, N
    LUKE, B
    [J]. LANCET, 1994, 344 (8924) : 703 - 707
  • [4] A PROSPECTIVE, RANDOMIZED TRIAL OF HIGH-DOSE INTRAVENOUS IMMUNE GLOBULIN G THERAPY, ORAL PREDNISONE THERAPY, AND NO THERAPY IN CHILDHOOD ACUTE IMMUNE THROMBOCYTOPENIC PURPURA
    BLANCHETTE, VS
    LUKE, B
    ANDREW, M
    SOMMERVILLENIELSEN, S
    BARNARD, D
    DEVEBER, B
    GENT, M
    [J]. JOURNAL OF PEDIATRICS, 1993, 123 (06) : 989 - 995
  • [5] Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study
    Bussel, James B.
    de Miguel, Purificacion Garcia
    Despotovic, Jenny M.
    Grainger, John D.
    Sevilla, Julian
    Blanchette, Victor S.
    Krishnamurti, Lakshmanan
    Connor, Philip
    David, Michele
    Boayue, Koh B.
    Matthews, Dana C.
    Lambert, Michele P.
    Marcello, Lisa M.
    Iyengar, Malini
    Chan, Geoffrey W.
    Chagin, Karen D.
    Theodore, Dickens
    Bailey, Christine K.
    Bakshi, Kalpana K.
    [J]. LANCET HAEMATOLOGY, 2015, 2 (08): : E315 - E325
  • [6] A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia
    Bussel, James B.
    Buchanan, George R.
    Nugent, Diane J.
    Gnarra, David J.
    Bomgaars, Lisa R.
    Blanchette, Victor S.
    Wang, Yow-Ming
    Nie, Kun
    Jun, Susie
    [J]. BLOOD, 2011, 118 (01) : 28 - 36
  • [7] Immune thrombocytopenia in two infant cases managed with eltrombopag
    Ceglie, Giulia
    Nocentini, Giulia
    De Gennaro, Francesca
    Clemente, Vitangelo
    Di Mauro, Margherita
    Palumbo, Giuseppe
    [J]. PEDIATRIC BLOOD & CANCER, 2021, 68 (09)
  • [8] The pathogenesis of immune thrombocytopaenic purpura
    Cooper, N
    Bussel, J
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 (04) : 364 - 374
  • [9] An update on pediatric ITP: differentiating primary ITP, IPD, and PID
    Grace, Rachael F.
    Lambert, Michele P.
    [J]. BLOOD, 2022, 140 (06) : 542 - 555
  • [10] Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia
    Grainger, John D.
    Kuhne, Thomas
    Hippenmeyer, Jane
    Cooper, Nichola
    [J]. ANNALS OF HEMATOLOGY, 2021, 100 (09) : 2143 - 2154